Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Restructuring Costs (2024 - 2026)

Clene (CLNN) posted Restructuring Costs of $58000.0 for Q2 2026, up 18.37% on a QoQ basis from $49000.0 in Q4 2025, and down 31.76% year-over-year from $85000.0 in Q2 2025.

Analysis

Clene (CLNN) Restructuring Costs (2024 - 2026) Analysis & Trends

Clene has reported Restructuring Costs for 3 years, with the latest figure at $58000.0 in Q2 2026.

  • On a quarterly basis, Restructuring Costs fell 31.76% year-over-year to $58000.0 in Q2 2026; TTM through Jun 2026 was $285000.0, a 57.96% decrease from a year earlier, with the FY2025 full-year figure at $318000.0, down 71.56% from the prior year.
  • Restructuring Costs was $58000.0 for Q2 2026 at Clene, up from $49000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $349000.0 in Q2 2024, with the low at $49000.0 in Q4 2025.
  • Average Restructuring Costs over 3 years is $166000.0, with a median of $93000.0 recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Restructuring Costs plunged 75.64% in 2025, then plunged 31.76% in 2026.
  • Over 3 years, Restructuring Costs stood at $174000.0 in 2024, then sank by 71.84% to $49000.0 in 2025, then increased by 18.37% to $58000.0 in 2026.
  • The last three Restructuring Costs figures came in at $58000.0 (Q2 2026), $49000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 Clene 45.69 Mn 45.69 Mn 54,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58,000.00
Dec 31, 2025 49,000.00
Sep 30, 2025 93,000.00
Jun 30, 2025 85,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 174,000.00
Sep 30, 2024 328,000.00
Jun 30, 2024 349,000.00
Mar 31, 2024 267,000.00